Biernat, Kristen A.
Pellock, Samuel J.
Bhatt, Aadra P.
Bivins, Marissa M.
Walton, William G.
Tran, Bich Ngoc T.
Wei, Lianjie
Snider, Michael C.
Cesmat, Andrew P.
Tripathy, Ashutosh
Erie, Dorothy A.
Redinbo, Matthew R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (CA098468, CA207416)
Article History
Received: 13 August 2018
Accepted: 14 November 2018
First Online: 29 January 2019
Competing Interests
: M.R.R. is the scientific founder of Symberix, Inc., which is developing microbiome-targeted therapeutics.